DENVER A Colorado man in his 20s has been reported as the first in the U.S. with the more contagious variant of the coronavirus.
He’s from a mostly rural expanse outside the Denver area and recovering in isolation, according to state officials. His condition was not disclosed.
The new, mutated version was first identified in Britain and found in several other countries.
Colorado Gov. Jared Polis says officials will “closely monitor this case, as well as all COVID-19 indicators, very closely.”
The variant is probably still rare in the U.S., but the lack of travel history in the first case means it is spreading, perhaps seeded by visitors from Britain in November or December, said scientist Trevor Bedford, who studies the spread of COVID-19 at the Fred Hutchinson Cancer Research Center in Seattle.
China s Sinopharm says its vaccine 79% effective against Covid-19
The United Arab Emirates approved a Sinopharm vaccine earlier this month, becoming the first foreign country to approve a China-developed Covid-19 vaccine.
(REUTERS)
. Updated: 30 Dec 2020, 12:34 PM IST AFP
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic
Share Via
Read Full Story
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
The Latest: Highest-tier limits extended to most of England clintonherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clintonherald.com Daily Mail and Mail on Sunday newspapers.
Sinopharm has applied to China s drug regulator for approval of the inactivated coronavirus vaccine.
Beijing, China:
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
China has been racing against the West to develop its own Covid-19 vaccines, with five already in large-scale Phase 3 clinical trials.
But Wednesday s announced was the first data released regarding the efficacy of a Chinese vaccine candidate. The protective effect of the (Sinopharm CNBG Beijing) vaccine against Covid-19 is 79.34 percent, said the Beijing Institute of Biological Products, a Sinopharm subsidiary.
The Latest: Colorado man in his 20s has variant of virus wsiltv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsiltv.com Daily Mail and Mail on Sunday newspapers.